Login / Signup

Serum Myostatin at Dialysis Initiation May Predict 1-Year Mortality and Hospitalization.

Midori SakashitaYoshifumi HamasakiRikako OkiYohei KomaruYoshihisa MiyamotoTeruhiko YoshidaRyo MatsuuraKent DoiMasaomi Nangaku
Published in: Nephron (2024)
Serum myostatin concentration at dialysis initiation is inversely associated with adverse outcomes in these dialysis-initiated patients.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • newly diagnosed
  • ejection fraction
  • cardiovascular events
  • patient reported outcomes